Status:
UNKNOWN
Efficacy and Safety of Cettum for Knee Osteoarthritis
Lead Sponsor:
Eun Jung Kim
Collaborating Sponsors:
DongGuk University
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The purpose of this study is verify the efficacy and safety of Cettum (Electric moxibustion) for patients with knee osteoarthritis.
Detailed Description
The investigator targets the patients with knee osteoarthritis. After treatment in 3 groups - Cettum treatment, traditional indirect moxibustion treatment, and usual care groups - the investigators wi...
Eligibility Criteria
Inclusion
- At least 40 years of age, but below 70 years of age
- Presence of knee osteoarthritis diagnosed according to American College of Rheumatology classification criteria and satisfying the following 2 conditions
- Knee pain when weight load in one or both knees in the last 6 months
- Knee pain rated \>4cm on a 10cm Visual Analog Scale (VAS)
- Feeling temperature sense to distinguish temperature differences
- An understanding of the objectives and methods of the clinical trial, and willingness in completing the consent form
- Those who are reliable and willing to cooperate in this test, and obey the restrictions for the next 3 months
Exclusion
- Trauma to the knee(s) within 6 months prior to enrollment, causing pain or functional problems
- Surgery on the knee(s) within 6 months prior to enrollment, causing pain or functional problems
- A history of intra-articular injection within the last 3 months
- A physical or laboratory finding indicating presence of an inflammatory arthritis (e.g. rheumatoid arthritis, autoimmune disease)
- Presence of physical or psychiatric disorder that may affect moxibustion treatment
- Presence of neurological disorder including paralysis symptoms on local or general sensation
- A female who is pregnant or is lactating
- Being afraid of moxibustion treatment or expected to cause side effects
- When researchers evaluate that it is not appropriate to participate in this clinical test
Key Trial Info
Start Date :
September 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT03287570
Start Date
September 20 2017
End Date
December 1 2018
Last Update
October 19 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongguk University Ilsan Oriental Hospital
Goyang-si, Gyeonggi-do, South Korea, 10326
2
Dongguk University Bundang Oriental Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13601